Neurocrine Biosciences (NBIX) Inventory (2017 - 2026)
Neurocrine Biosciences (NBIX) posted quarterly Inventory of $104.2 million for Q2 2026, up 83.13% year-over-year from $56.9 million in Q2 2025, and up 61.55% on a QoQ basis from $64.5 million in Q1 2026.
Neurocrine Biosciences (NBIX) Inventory (2017 - 2026) Analysis & Trends
Neurocrine Biosciences has reported Inventory for 10 years, with the latest figure at $104.2 million in Q2 2026.
- Inventory for Q2 2026 came in at $104.2 million, up 83.13% year-over-year; the trailing twelve-month figure through Jun 2026 was $104.2 million (up 83.13% YoY), and the FY2025 annual result was $69.0 million, up 20.21% from the prior year.
- Inventory grew to $104.2 million in Q2 2026, from $64.5 million in the prior quarter.
- Over five years, Inventory peaked at $104.2 million in Q2 2026 and troughed at $28.8 million in Q3 2023.
- A 5-year average of $48.2 million and a median of $40.4 million in 2023 frame the typical range for Inventory.
- The widest annual swing landed in 2023, when Inventory slipped 22.16%; it then soared 83.13% in 2026.
- A 5-year view of Inventory shows it stood at $35.1 million in 2022, then rose by 9.12% to $38.3 million in 2023, then jumped by 49.87% to $57.4 million in 2024, then increased by 20.21% to $69.0 million in 2025, then surged by 51.01% to $104.2 million in 2026.
- Per Business Quant data, the three most recent Inventory figures were $104.2 million in Q2 2026, $64.5 million in Q1 2026, and $69.0 million in Q4 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Inventory (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.65 Bn | 42.68 Bn | - | 1.44 Bn |
| 2 | Teva Pharmaceutical Industries | 43.09 Bn | 39.44 Bn | 2.15 Bn | 3.22 Bn |
| 3 | Zoetis | 31.54 Bn | 29.86 Bn | 1.05 Bn | 2.57 Bn |
| 4 | Takeda Pharmaceutical | 28.61 Bn | 22.81 Bn | 5.10 Bn | 9.08 Bn |
| 5 | United Therapeutics | 22.11 Bn | 19.45 Bn | 683.80 Mn | 193.80 Mn |
| 6 | Viatris | 18.77 Bn | 17.88 Bn | 1.46 Bn | 3.93 Bn |
| 7 | Neurocrine Biosciences | 15.62 Bn | 15.23 Bn | 935.80 Mn | 104.20 Mn |
| 8 | Elanco Animal Health | 12.07 Bn | 11.54 Bn | 798.00 Mn | 1.77 Bn |
| 9 | Dr Reddys Laboratories | 10.09 Bn | 9.93 Bn | - | 816.00 Mn |
| 10 | Alkermes | 8.20 Bn | 7.54 Bn | 397.90 Mn | 298.96 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 104.20 Mn |
| Mar 31, 2026 | 64.50 Mn |
| Dec 31, 2025 | 69.00 Mn |
| Sep 30, 2025 | 69.30 Mn |
| Jun 30, 2025 | 56.90 Mn |
| Mar 31, 2025 | 59.10 Mn |
| Dec 31, 2024 | 57.40 Mn |
| Sep 30, 2024 | 45.80 Mn |
| Jun 30, 2024 | 42.50 Mn |
| Mar 31, 2024 | 37.20 Mn |
| Dec 31, 2023 | 38.30 Mn |
| Sep 30, 2023 | 28.80 Mn |
| Jun 30, 2023 | 31.70 Mn |
| Mar 31, 2023 | 33.40 Mn |
| Dec 31, 2022 | 35.10 Mn |
| Sep 30, 2022 | 37.00 Mn |
| Jun 30, 2022 | 29.30 Mn |
| Mar 31, 2022 | 29.00 Mn |
| Dec 31, 2021 | 30.50 Mn |
| Sep 30, 2021 | 25.50 Mn |